Skip to content
Home/Companies/MedTech/ArgusEye

ArgusEye

MedTech·Sweden·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns ArgusEye?

ArgusEye is currently owned by Eir Ventures through Eir Ventures I (2020 vintage), since 2021.

Hand-verified · updated 2026-08-17

Eir Ventures
Investor
Eir Ventures
Eir Ventures I · 2020 · Life Sciences VC

Key facts

HQSweden
SectorMedTech
StatusActive

More from Eir Ventures I

Other portfolio companies in the same fund.

Moleculent
Active
BiotechSweden· 2024
Purpose Pharma
Active
PharmaSweden· 2024
Dania Tx
Active
BiotechDenmark· 2023
GutCRINE
Active
BiotechDenmark· 2023
RAPP
Active
HealthTechSweden· 2023
Scenic Biotech
Scenic Biotech
Active
BiotechNetherlands· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track ArgusEye

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy ArgusEye?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on ArgusEye.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue